INTP — Integrated Pharmaceuticals Income Statement
0.000.00%
Last trade - 00:00
HealthcareHighly SpeculativeMicro Cap
2003 December 31st | 2004 December 31st | 2005 December 31st | 2006 December 31st | 2007 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10KSB | 10KSB | 10KSB | 10KSB | 10KSB |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.045 | 0 | 0.077 | 0.061 | 0.035 |
Cost of Revenue | |||||
Gross Profit | 0.016 | 0 | 0.032 | 0.005 | 0.023 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Total Operating Expenses | 1.02 | 6.3 | 3.93 | 2.19 | 1.86 |
Operating Profit | -0.979 | -6.3 | -3.85 | -2.13 | -1.83 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -1.2 | -7.49 | -3.86 | -2.14 | -1.83 |
Provision for Income Taxes | |||||
Net Income After Taxes | -1.2 | -7.49 | -3.86 | -2.14 | -1.83 |
Net Income Before Extraordinary Items | |||||
Net Income | -1.2 | -7.49 | -3.86 | -2.14 | -1.83 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | -1.2 | -7.49 | -3.86 | -2.14 | -1.83 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.151 | -0.537 | -0.168 | -0.093 | -0.045 |
Dividends per Share |